L David Waterbury

Summary

Affiliation: University of Vermont
Country: USA

Publications

  1. ncbi request reprint Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium
    L David Waterbury
    Pacific BioLabs, Hercules, CA 94070, USA
    Curr Med Res Opin 22:1133-40. 2006
  2. ncbi request reprint Comparison of ketorolac tromethamine, diclofenac sodium, and loteprednol etabonate in an animal model of ocular inflammation
    L David Waterbury
    J Ocul Pharmacol Ther 22:155-9. 2006
  3. ncbi request reprint Efficacy of low concentrations of ketorolac tromethamine in animal models of ocular inflammation
    L David Waterbury
    Department of Ophthalmology, University of California, San Francisco School of Medicine, San Francisco, CA, USA
    J Ocul Pharmacol Ther 20:345-52. 2004
  4. doi request reprint Re: Pharmacokinetics and pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac
    Frank A Bucci
    J Cataract Refract Surg 34:1226; author reply 1226-7. 2008
  5. doi request reprint Comparison of ketorolac 0.4% and bromfenac 0.09% at trough dosing: aqueous drug absorption and prostaglandin E2 levels
    Frank A Bucci
    Bucci Laser Vision Institute, 158 Wilkes Barre Township Boulevard, Wilkes Barre, PA 18702, USA
    J Cataract Refract Surg 34:1509-12. 2008
  6. ncbi request reprint Prostaglandin E2 inhibition and aqueous concentration of ketorolac 0.4% (acular LS) and nepafenac 0.1% (nevanac) in patients undergoing phacoemulsification
    Frank A Bucci
    Bucci Laser Vision Institute, Wilkes Barre, Pennsylvania 18702, USA
    Am J Ophthalmol 144:146-7. 2007

Collaborators

Detail Information

Publications6

  1. ncbi request reprint Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium
    L David Waterbury
    Pacific BioLabs, Hercules, CA 94070, USA
    Curr Med Res Opin 22:1133-40. 2006
    ..To compare the cyclooxygenase (COX) activity and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs (NSAIDs) ketorolac tromethamine (ketorolac) and bromfenac sodium (bromfenac)...
  2. ncbi request reprint Comparison of ketorolac tromethamine, diclofenac sodium, and loteprednol etabonate in an animal model of ocular inflammation
    L David Waterbury
    J Ocul Pharmacol Ther 22:155-9. 2006
    ..The aim of this study was to compare the anti-inflammatory activities of ketorolac tromethamine 0.4% and 0.1%; diclofenac sodium 0.1%; and loteprednol etabonate 0.5% suspension in an animal model of ocular inflammation...
  3. ncbi request reprint Efficacy of low concentrations of ketorolac tromethamine in animal models of ocular inflammation
    L David Waterbury
    Department of Ophthalmology, University of California, San Francisco School of Medicine, San Francisco, CA, USA
    J Ocul Pharmacol Ther 20:345-52. 2004
    ..To determine if topical ophthalmic application of ketorolac tromethamine concentrations below 0.5% can block the biochemical and physiological processes associated with chemically induced ocular inflammation in rabbits...
  4. doi request reprint Re: Pharmacokinetics and pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac
    Frank A Bucci
    J Cataract Refract Surg 34:1226; author reply 1226-7. 2008
  5. doi request reprint Comparison of ketorolac 0.4% and bromfenac 0.09% at trough dosing: aqueous drug absorption and prostaglandin E2 levels
    Frank A Bucci
    Bucci Laser Vision Institute, 158 Wilkes Barre Township Boulevard, Wilkes Barre, PA 18702, USA
    J Cataract Refract Surg 34:1509-12. 2008
    ..To compare aqueous drug concentrations and prostaglandin E(2) (PGE(2)) levels in patients treated with ketorolac 0.4% and bromfenac 0.09% at trough dosing...
  6. ncbi request reprint Prostaglandin E2 inhibition and aqueous concentration of ketorolac 0.4% (acular LS) and nepafenac 0.1% (nevanac) in patients undergoing phacoemulsification
    Frank A Bucci
    Bucci Laser Vision Institute, Wilkes Barre, Pennsylvania 18702, USA
    Am J Ophthalmol 144:146-7. 2007
    ..To determine the prostaglandin E(2) (PGE(2)) levels and aqueous concentrations achieved with ketorolac 0.4% (Acular LS; Allergan, Inc, Irvine, California, USA) and nepafenac 0.1% (Nevanac; Alcon Laboratories, Inc, Fort Worth, Texas, USA)...